This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Corvas International, Inc., Intercept Pharmaceuticals, Inc.. Active years: 2004-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2021
Title: Ronald D Lewis, II: Innovator in Pharmaceutical Chemistry
Introduction
Ronald D Lewis, II is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceutical chemistry, holding 2 patents that focus on innovative methods and compounds.
Latest Patents
Lewis's latest patents include "Methods and intermediates for the preparation of bile acid derivatives." This patent relates to methods and novel intermediates useful in the preparation of a compound of formula I or its pharmaceutically acceptable derivatives. The process involves reacting a compound of formula I-4 with a halogenating reagent to yield a compound of formula I-5a. Another significant patent is for "Plasminogen activator inhibitor antagonists." This patent provides compounds and pharmaceutical compositions that are useful as plasminogen activator inhibitor (PAI) antagonists, detailing methods of antagonizing PAI with various substituted and unsubstituted aryl and heteroaryl compounds.
Career Highlights
Throughout his career, Lewis has worked with prominent companies in the pharmaceutical industry, including Corvas International, Inc. and Intercept Pharmaceuticals, Inc. His work has contributed to advancements in drug development and therapeutic applications.
Collaborations
Lewis has collaborated with notable professionals in his field, including Edwin L Madison and Terence Kevin Brunck. These collaborations have further enhanced his contributions to pharmaceutical innovations.
Conclusion
Ronald D Lewis, II is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable patents and collaborations. His innovative approaches continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
